<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">27437084</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>07</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1948-5875</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>7</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Jul</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>ACS medicinal chemistry letters</Title>
                <ISOAbbreviation>ACS Med Chem Lett</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>719-23</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsmedchemlett.6b00185</ELocationID>
            <Abstract>
                <AbstractText>We report the discovery of PDE10A PET tracer AMG 580 developed to support proof of concept studies with PDE10A inhibitors in the clinic. To find a tracer with higher binding potential (BPND) in NHP than our previously reported tracer 1, we implemented a surface plasmon resonance assay to measure the binding off-rate to identify candidates with slower washout rate in vivo. Five candidates (2-6) from two structurally distinct scaffolds were identified that possessed both the in vitro characteristics that would favor central penetration and the structural features necessary for PET isotope radiolabeling. Two cinnolines (2, 3) and one keto-benzimidazole (5) exhibited PDE10A target specificity and brain uptake comparable to or better than 1 in the in vivo LC-MS/MS kinetics distribution study in SD rats. In NHP PET imaging study, [(18)F]-5 produced a significantly improved BPND of 3.1 and was nominated as PDE10A PET tracer clinical candidate for further studies. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Essa</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Ning</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kunz</LastName>
                    <ForeName>Roxanne K</ForeName>
                    <Initials>RK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hwang</LastName>
                    <ForeName>Dah-Ren</ForeName>
                    <Initials>DR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Michelsen</LastName>
                    <ForeName>Klaus</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Structure and Characterization, Amgen Inc. , 360 Binney Street, Cambridge, Massachusetts 02142, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Davis</LastName>
                    <ForeName>Carl</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Ji</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience and Department of Pharmacokinetics and Drug Metabolism, Amgen Inc. , 1120 Veterans Boulevard, South San Francisco, California 94080, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Jianxia</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience and Department of Pharmacokinetics and Drug Metabolism, Amgen Inc. , 1120 Veterans Boulevard, South San Francisco, California 94080, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lester-Zeiner</LastName>
                    <ForeName>Dianna</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience and Department of Pharmacokinetics and Drug Metabolism, Amgen Inc. , 1120 Veterans Boulevard, South San Francisco, California 94080, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hungate</LastName>
                    <ForeName>Randall</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Treanor</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hang</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience and Department of Pharmacokinetics and Drug Metabolism, Amgen Inc. , 1120 Veterans Boulevard, South San Francisco, California 94080, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Allen</LastName>
                    <ForeName>Jennifer R</ForeName>
                    <Initials>JR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Department of Pharmacokinetics and Drug Metabolism, Department of Neuroscience, and Department of Early Development, Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 93012-1799, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>05</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>ACS Med Chem Lett</MedlineTA>
            <NlmUniqueID>101521073</NlmUniqueID>
            <ISSNLinking>1948-5875</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Phosphodiesterase</Keyword>
            <Keyword MajorTopicYN="N">brain penetration</Keyword>
            <Keyword MajorTopicYN="N">positron emission tomography</Keyword>
            <Keyword MajorTopicYN="N">radiotracer</Keyword>
            <Keyword MajorTopicYN="N">receptor occupancy</Keyword>
            <Keyword MajorTopicYN="N">tracer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>05</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>05</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27437084</ArticleId>
            <ArticleId IdType="doi">10.1021/acsmedchemlett.6b00185</ArticleId>
            <ArticleId IdType="pmc">PMC4948002</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2012 Mar 15;22(6):2262-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22365755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2012 Nov 15;22(22):6938-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23044369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Imaging Biol. 2003 Nov-Dec;5(6):350-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14667490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2015 Feb;352(2):327-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25502803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Angew Chem Int Ed Engl. 2008;47(47):8998-9033</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18988199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Pharmacol Sci. 2009 Aug;30(8):431-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19616318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucl Med Biol. 2015 Aug;42(8):654-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25935386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucl Med Biol. 2014 Apr;41(4):343-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24607437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2012 Dec 15;22(24):7371-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23149228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2012 May 24;55(10 ):4776-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22548439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Med Chem Lett. 2014 Mar 28;5(6):700-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24944747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2014 Aug 14;57(15):6632-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25062128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem. 2014 Dec 1;22(23):6570-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25456383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Chem. 2013 Nov 14;56(21):8781-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24102193</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>